If you are not happy with the results below please do another search
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is based in the UK with offices at the Sussex Innovation Centre.
- The pharmacology of novel TMEM16A potentiator compoundsApril 2, 2019 - 10:54 am
- TMEM16A channel function does not influence goblet cell numbers in the human airway epitheliumApril 2, 2019 - 10:51 am
- EACT increases intracellular calcium levels by a TMEM16A-independent mechanismApril 2, 2019 - 10:41 am
- Enterprise Therapeutics strengthens leadership team, appoints Amit D. Munshi as Non-Executive ChairmanMarch 25, 2019 - 9:35 am
Follow Us On Twitter
Looking forward to seeing everyone @CF_Foundation Research Conference today. Look out for "Something old and something new: ENaC & TMEM16A as targets to hydrate #mucus in the #CF #airway", presented by Dr Henry Danahay, our Head of Biology: https://t.co/fBlXAVQGi7